-
-
-
-
-
-
-
Protagonist Therapeutics (PTGX) PT Raised to $112 at BMO Capital
-
-
-
-
-
-
-
Takeda (TAK) and Protagonist Therapeutics (PTGX) Enter Global License and Collaboration Agreement for Rusfertide
-
-
-
-
-
-
-
Protagonist Therapeutics Reports Granting of Inducement Awards
-
-
-
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

